| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/25/2007 | CA2279904C Method for measuring the components of a coating on a moving base material |
| 09/25/2007 | CA2219872C Use of certain amides as probes for detection of antitubulin activity and resistance monitoring |
| 09/25/2007 | CA2214018C An immortalized mammal hybridoma fusion partner |
| 09/25/2007 | CA2183758C Human papilloma virus detection in a nucleic acid amplification process using general primers |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/25/2007 | CA2143898C A process for reactivating purified membrane proteins by freezing them |
| 09/25/2007 | CA2132868C Method of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 09/25/2007 | CA2112701C Proteins s polypeptides and uses thereof |
| 09/24/2007 | CA2547512A1 Chlorine monitor & recorder for water distribution systems |
| 09/23/2007 | CA2582761A1 Markers of pre-term labor |
| 09/23/2007 | CA2582002A1 Composition for measuring concentration of residual chlorine |
| 09/21/2007 | CA2581109A1 Modulator of gamma secretase |
| 09/21/2007 | CA2540626A1 A sensor arrangement |
| 09/20/2007 | WO2007106868A2 Cell culture devices having ultrathin porous membrane and uses thereof |
| 09/20/2007 | WO2007106838A2 A non-invasive method for diagnosing fetal cells and cancer cells |
| 09/20/2007 | WO2007106837A2 Method for combining immunostaining and fish using covalently binding fluorophores |
| 09/20/2007 | WO2007106800A2 In vivo induced genes of mycobacterium tuberculosis |
| 09/20/2007 | WO2007106762A2 Alzheimer's disease biomarkers and methods of use |
| 09/20/2007 | WO2007106598A2 Devices and methods for detecting cells and other analytes |
| 09/20/2007 | WO2007106595A1 Diagnosis and prognosis of dipeptidyl peptidase-associated disease states |
| 09/20/2007 | WO2007106580A2 Rapid magnetic flow assays |
| 09/20/2007 | WO2007106577A2 Gelsolin in the treatment and diagnosis of neurological disease |
| 09/20/2007 | WO2007106575A2 Automatable artificial immune system (ais) |
| 09/20/2007 | WO2007106560A2 Methods for detecting a mycobacterium tuberculosis infection |
| 09/20/2007 | WO2007106556A2 Method for performing a non-invasive blood gas test |
| 09/20/2007 | WO2007106474A2 Reduction of platelet interference in plasma assay samples |
| 09/20/2007 | WO2007106466A2 Beta-2 microglobulin as a biomarker for peripheral artery disease |
| 09/20/2007 | WO2007106432A2 Egf receptor phosphorylation status for disease treatment |
| 09/20/2007 | WO2007106413A2 Extended length borane phosphonate nucleic acid compounds |
| 09/20/2007 | WO2007106224A2 Method of detecting or diagnosing of a neurodegenerative disease or condition |
| 09/20/2007 | WO2007106140A2 Replaceable module for a breathalyzer |
| 09/20/2007 | WO2007106073A2 Modified pathogens for use as vaccines |
| 09/20/2007 | WO2007106050A1 Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody |
| 09/20/2007 | WO2007105954A1 Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes |
| 09/20/2007 | WO2007105680A1 Absorption pad for immunoassay, strip for immunoassay and immunoassay apparatus |
| 09/20/2007 | WO2007105676A1 Microchip and soi substrate for manufacturing microchip |
| 09/20/2007 | WO2007105623A1 Oligonucleotide-immobilized solid support |
| 09/20/2007 | WO2007105442A1 Therapeutic agent for food intake disorder or water intake disorder |
| 09/20/2007 | WO2007105363A1 Culture observation equipment |
| 09/20/2007 | WO2007105094A1 Method for the identification of new leads for drug candidates |
| 09/20/2007 | WO2007105081A2 Method for the measure of molecular interactions by measurement of the light reflected by planar surfaces |
| 09/20/2007 | WO2007105023A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 09/20/2007 | WO2007105022A1 Modulation of glutamine synthetase activity |
| 09/20/2007 | WO2007104994A1 Improvements in or relating to coating surfaces |
| 09/20/2007 | WO2007104962A1 Purification method and kits |
| 09/20/2007 | WO2007104835A1 Use of a growth-stimulating protein |
| 09/20/2007 | WO2007104825A1 Method for extracting gluten from processed and unprocessed foods by means of heat based on the use of ionic and non-ionic detergents |
| 09/20/2007 | WO2007104766A1 A dissolution sample preparation apparatus and method with both mechanical and ultrasonic homogenisation |
| 09/20/2007 | WO2007104763A1 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2 |
| 09/20/2007 | WO2007104724A2 Identification of osteoblast cells differentiation and bone tumor markers and uses thereof |
| 09/20/2007 | WO2007104685A1 Use of aryl- or alkyloxy-substituted phthalocyanines as marking substances for liquids |
| 09/20/2007 | WO2007104682A1 Means and methods for predicting cardiovascular complications in subjects suffering from osteoporosis |
| 09/20/2007 | WO2007104565A1 A system |
| 09/20/2007 | WO2007104556A1 Pat1-type protein assay |
| 09/20/2007 | WO2007104511A1 Cancer vaccine |
| 09/20/2007 | WO2007104427A1 Chimeric polypeptide molecule |
| 09/20/2007 | WO2007104314A2 INHIBITION OF GASCl |
| 09/20/2007 | WO2007104293A1 Device and method for the production of molded articles from moist concrete or materials of the same type |
| 09/20/2007 | WO2007104263A1 An enhancin of hepatitis b virus vaccine and its gene |
| 09/20/2007 | WO2007104181A1 Uses of dkk-1 protein in diagnosis of cancers |
| 09/20/2007 | WO2007104160A1 Identification of biomolecules through expression patterns in mass spectrometry |
| 09/20/2007 | WO2007090630A3 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same |
| 09/20/2007 | WO2007085461A3 Anticoagulation of human blood ex vivo |
| 09/20/2007 | WO2007085438A3 Stack magazine system |
| 09/20/2007 | WO2007084180A3 Airborne bacterial spores as an indicator of biomass in an indoor enviroment |
| 09/20/2007 | WO2007082757A3 Test systems for the analysis of polypeptides and cells adhering to silicones |
| 09/20/2007 | WO2007082144A9 B7-h1 and survivin in cancer |
| 09/20/2007 | WO2007079392A3 Real-time assays of neuro-humoral to assess cardiovascular stress |
| 09/20/2007 | WO2007078268A3 Methods and compositions for the detection and/or quantification of gram positive bacterial contaminants |
| 09/20/2007 | WO2007072311A3 A sensor for biomolecules and a method for preparing and using the same |
| 09/20/2007 | WO2007072013A3 Cholesterol sensor |
| 09/20/2007 | WO2007071856A3 Therapeutic treatments associated with a method for characterising a biologically active biochemical element by analysing low-frequency electromagnetic signals |
| 09/20/2007 | WO2007071855A3 Method for characterising a biologically active and particularly pathogenically active biochemical element by analysing low-frequency electromagnetic signals |
| 09/20/2007 | WO2007071250A3 Method for detection of l523s expression in biological samples |
| 09/20/2007 | WO2007070996A3 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
| 09/20/2007 | WO2007061995A3 Biomarkers for statin-induced myopathy or rhabdomyolysis |
| 09/20/2007 | WO2007056114B1 Compositions and methods for the detection of trypanosoma cruzi infection |
| 09/20/2007 | WO2007051218A3 Method using human or mouse isg12 for the development and production of medicaments and single nucleotide polymorphism in the isg12 gene for diagnostic purposes |
| 09/20/2007 | WO2007044906A3 Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides |
| 09/20/2007 | WO2007041611A3 Microtubule synthesis as a biomarker |
| 09/20/2007 | WO2007035842A3 Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
| 09/20/2007 | WO2007030391A3 Method for diagnosing infections |
| 09/20/2007 | WO2007028394A3 Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort |
| 09/20/2007 | WO2007025044A3 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 09/20/2007 | WO2007024661A3 Precise measurement of red blood cells in a blood sample |
| 09/20/2007 | WO2007022086A3 Antibodies and methods for predicting dental caries |
| 09/20/2007 | WO2007021628A3 Target and assay for lead compounds for polycystic kidney disease |
| 09/20/2007 | WO2007014749A3 Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor |
| 09/20/2007 | WO2007002217A3 Mutations and polymorphisms of bcl-2 |
| 09/20/2007 | WO2006106129A3 Polypeptide markers for the diagnosis of prostate cancer |
| 09/20/2007 | WO2006100366A3 Method and device for the separation of biological particles contained in a liquid by means of vertical filtration |
| 09/20/2007 | WO2006086771A3 Devices and methods for handling and processing punches |
| 09/20/2007 | WO2006007722A3 Method to optimize analyte and antibody substrate binding by least energy adsorption |
| 09/20/2007 | WO2005115135A3 Mouse model of crohn’s disease and a method to develop specific therapeutics |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | WO2005011590A3 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 09/20/2007 | WO2004089310A3 High-throughput assay for virus entry and drug screening |
| 09/20/2007 | WO2004065560A3 Methods of screening for modulators of nerve growth factor |
| 09/20/2007 | WO2004004649A3 Compositions and methods for the treatment of immune related diseases |
| 09/20/2007 | US20070220621 Genetic characterization and prognostic significance of cancer stem cells in cancer |